KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) EBITDA (2016 - 2025)

CareDx's EBITDA history spans 13 years, with the latest figure at -$6.0 million for Q4 2025.

  • For Q4 2025, EBITDA fell 108.09% year-over-year to -$6.0 million; the TTM value through Dec 2025 reached -$30.8 million, down 189.72%, while the annual FY2025 figure was -$30.8 million, 175.51% down from the prior year.
  • EBITDA for Q4 2025 was -$6.0 million at CareDx, down from -$246000.0 in the prior quarter.
  • Across five years, EBITDA topped out at $74.7 million in Q4 2024 and bottomed at -$122.6 million in Q4 2023.
  • The 5-year median for EBITDA is -$14.6 million (2021), against an average of -$15.3 million.
  • The largest annual shift saw EBITDA tumbled 2120.63% in 2022 before it surged 160.91% in 2024.
  • A 5-year view of EBITDA shows it stood at -$15.4 million in 2021, then decreased by 24.16% to -$19.1 million in 2022, then plummeted by 541.38% to -$122.6 million in 2023, then surged by 160.91% to $74.7 million in 2024, then plummeted by 108.09% to -$6.0 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's EBITDA are -$6.0 million (Q4 2025), -$246000.0 (Q3 2025), and -$11.1 million (Q2 2025).